248 related articles for article (PubMed ID: 27049477)
21. Inflammatory Properties of Diet and Glucose-Insulin Homeostasis in a Cohort of Iranian Adults.
Moslehi N; Ehsani B; Mirmiran P; Shivappa N; Tohidi M; Hébert JR; Azizi F
Nutrients; 2016 Nov; 8(11):. PubMed ID: 27869717
[TBL] [Abstract][Full Text] [Related]
22. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort.
Pivovarova O; Nikiforova VJ; Pfeiffer AF; Rudovich N
Diabetes Metab Res Rev; 2009 Feb; 25(2):156-62. PubMed ID: 19117022
[TBL] [Abstract][Full Text] [Related]
23. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
[TBL] [Abstract][Full Text] [Related]
24. Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.
Potier L; Roussel R; Marre M; Bjornstad P; Cherney DZ; El Boustany R; Fumeron F; Venteclef N; Gautier JF; Hadjadj S; Mohammedi K; Velho G
Diabetes Care; 2019 Dec; 42(12):2290-2297. PubMed ID: 31582427
[TBL] [Abstract][Full Text] [Related]
25. Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome.
Saleem U; Khaleghi M; Morgenthaler NG; Bergmann A; Struck J; Mosley TH; Kullo IJ
J Clin Endocrinol Metab; 2009 Jul; 94(7):2558-64. PubMed ID: 19366852
[TBL] [Abstract][Full Text] [Related]
26. Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study.
Cauchi S; Proença C; Choquet H; Gaget S; De Graeve F; Marre M; Balkau B; Tichet J; Meyre D; Vaxillaire M; Froguel P;
J Mol Med (Berl); 2008 Mar; 86(3):341-8. PubMed ID: 18210030
[TBL] [Abstract][Full Text] [Related]
27. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study.
Fumeron F; Aubert R; Siddiq A; Betoulle D; Péan F; Hadjadj S; Tichet J; Wilpart E; Chesnier MC; Balkau B; Froguel P; Marre M;
Diabetes; 2004 Apr; 53(4):1150-7. PubMed ID: 15047634
[TBL] [Abstract][Full Text] [Related]
28. [The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits].
Xiang K; Fang Q; Zheng T; Jia W; Wang Y; Zhang R; Li J; Shen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):426-30. PubMed ID: 11774208
[TBL] [Abstract][Full Text] [Related]
29. Positive association between high-sensitivity C-reactive protein and incidence of type 2 diabetes mellitus in Japanese workers: 6-year follow-up.
Wang C; Yatsuya H; Tamakoshi K; Uemura M; Li Y; Wada K; Yamashita K; Kawaguchi L; Toyoshima H; Aoyama A
Diabetes Metab Res Rev; 2013 Jul; 29(5):398-405. PubMed ID: 23463453
[TBL] [Abstract][Full Text] [Related]
30. Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder.
Mansur RB; Rizzo LB; Santos CM; Asevedo E; Cunha GR; Noto MN; Pedrini M; Zeni-Graiff M; Cordeiro Q; McIntyre RS; Brietzke E
Psychiatry Clin Neurosci; 2017 Sep; 71(9):624-636. PubMed ID: 28457001
[TBL] [Abstract][Full Text] [Related]
31. Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility.
Guigas B; de Leeuw van Weenen JE; van Leeuwen N; Simonis-Bik AM; van Haeften TW; Nijpels G; Houwing-Duistermaat JJ; Beekman M; Deelen J; Havekes LM; Penninx BW; Vogelzangs N; van 't Riet E; Dehghan A; Hofman A; Witteman JC; Uitterlinden AG; Grarup N; Jørgensen T; Witte DR; Lauritzen T; Hansen T; Pedersen O; Hottenga J; Romijn JA; Diamant M; Kramer MH; Heine RJ; Willemsen G; Dekker JM; Eekhoff EM; Pijl H; de Geus EJ; Slagboom PE; 't Hart LM
Diabet Med; 2014 Aug; 31(8):1001-8. PubMed ID: 24724616
[TBL] [Abstract][Full Text] [Related]
32. Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes.
Wang CB; Zong M; Lu SQ; Tian Z
J Diabetes Complications; 2016; 30(8):1532-1536. PubMed ID: 27554438
[TBL] [Abstract][Full Text] [Related]
33. Relation between human vasopressin 1a gene variance, fat intake, and diabetes.
Enhörning S; Leosdottir M; Wallström P; Gullberg B; Berglund G; Wirfält E; Melander O
Am J Clin Nutr; 2009 Jan; 89(1):400-6. PubMed ID: 19056558
[TBL] [Abstract][Full Text] [Related]
34. Association of ketone body levels with hyperglycemia and type 2 diabetes in 9,398 Finnish men.
Mahendran Y; Vangipurapu J; Cederberg H; Stancáková A; Pihlajamäki J; Soininen P; Kangas AJ; Paananen J; Civelek M; Saleem NK; Pajukanta P; Lusis AJ; Bonnycastle LL; Morken MA; Collins FS; Mohlke KL; Boehnke M; Ala-Korpela M; Kuusisto J; Laakso M
Diabetes; 2013 Oct; 62(10):3618-26. PubMed ID: 23557707
[TBL] [Abstract][Full Text] [Related]
35. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
Enhörning S; Bankir L; Bouby N; Struck J; Hedblad B; Persson M; Morgenthaler NG; Nilsson PM; Melander O
Int J Obes (Lond); 2013 Apr; 37(4):598-603. PubMed ID: 22614056
[TBL] [Abstract][Full Text] [Related]
36. Copeptin predicts coronary artery disease cardiovascular and total mortality.
Tasevska I; Enhörning S; Persson M; Nilsson PM; Melander O
Heart; 2016 Jan; 102(2):127-32. PubMed ID: 26661323
[TBL] [Abstract][Full Text] [Related]
37. Copeptin and arginine vasopressin concentrations in critically ill patients.
Jochberger S; Morgenthaler NG; Mayr VD; Luckner G; Wenzel V; Ulmer H; Schwarz S; Hasibeder WR; Friesenecker BE; Dünser MW
J Clin Endocrinol Metab; 2006 Nov; 91(11):4381-6. PubMed ID: 16940457
[TBL] [Abstract][Full Text] [Related]
38. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
Fu SN; Luk W; Wong CK; Cheung KL
J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
[TBL] [Abstract][Full Text] [Related]
39. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
Fiorentino TV; Marini MA; Andreozzi F; Arturi F; Succurro E; Perticone M; Sciacqua A; Hribal ML; Perticone F; Sesti G
J Clin Endocrinol Metab; 2015 Oct; 100(10):3744-51. PubMed ID: 26274345
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
